1.
J Neurol Neurosurg Psychiatry
; 78(9): 1012-3, 2007 Sep.
Article
in English
| MEDLINE
| ID: mdl-17702789
Subject(s)
Guillain-Barre Syndrome/drug therapy , Immunosuppressive Agents/administration & dosage , Mycophenolic Acid/analogs & derivatives , Adult , Aged , Anti-Inflammatory Agents/administration & dosage , Drug Therapy, Combination , Female , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Methylprednisolone/administration & dosage , Middle Aged , Mycophenolic Acid/administration & dosage , Pilot Projects
2.
Biochem Biophys Res Commun
; 129(2): 431-8, 1985 Jun 14.
Article
in English
| MEDLINE
| ID: mdl-2990456
ABSTRACT
12-O-Tetradecanoyl-phorbol-13-acetate, a comitogen for lymphocytes, suppresses the concanavalin A-induced accumulation of 3 2P-phosphatidyl-inositol, in mouse spleen lymphocytes incubated with 3 2P-orthophosphate. The comitogenic tumor promoter does not affect the rate of de novo synthesis of phosphatidylinositol, as measured by [3H]-glycerol incorporation. Mitogen stimulates the incorporation of [3 2P]-phosphate into phosphatidylinositol, phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate, but the tumor promoter suppresses only the increased labelling of the phosphatidylinositol, while it enhances phosphorylation of the polyphosphoinositides.